Pharmaceutical preparation manufacturing — US Industry Report
The pharmaceutical preparation manufacturing industry in the United States generated an estimated ~$155.6B in annual revenue across 1.4K establishments employing 170.0K workers (Census Bureau). This 38-page report analyzes industry performance, competitive dynamics, and delivers 5-year growth forecasts.
Industry Snapshot
- ▸Pharma manufacturing maintains competitive wage structures while constraining labor costs relative to revenue
- ▸Regional concentration persists alongside fragmented competitive landscape of smaller manufacturers
- ▸Payroll growth substantially outpacing revenue expansion over the past decade
- ▸Employment expansion significantly outpacing broader economic growth in an ostensibly mature sector
Table of Contents
Key takeaways, industry definition, and current state overview. Covers the industry's scope, principal activities, NAICS classification context, and a concise snapshot of where the industry stands today. Reading this alone gives decision-makers the high-level picture they need before diving into data-backed chapters.
Historical performance analysis covering establishments, employment, and payroll (2012-2025). Examines what has driven industry performance in recent years, how the industry has responded to macroeconomic cycles, and which operating conditions have shaped revenue and labor dynamics. Includes source-cited tables and year-by-year data points.
5-year projections (2026-2030) with base case, bull case, and bear case scenarios. Each scenario combines historical trends, macroeconomic indicators from FRED, and industry-specific signals. Addresses questions on expected trajectory, forecast risk, downside drivers, and the assumptions behind each scenario.
Growth drivers, risk factors, and external environment analysis. Unpacks the forces that will shape the industry over the forecast horizon — demographic shifts, regulatory changes, technology adoption, and cyclical exposure. Frames both the upside opportunities and the structural risks operators and investors should weigh.
Market structure, concentration, barriers to entry, and competitive dynamics. Describes how the industry is structured between incumbents and entrants, typical competitive strategies, and what separates successful operators. Standard-tier reports add the official CR4, CR8, CR20, CR50 and HHI from the Census Economic Census, plus the largest public operators named from SEC EDGAR 10-K filings.
Cost structure, labor requirements, technology factors, and the regulatory environment. Examines where operators spend, how sensitive margins are to input costs, what workforce and technology investments are typical, and which compliance and regulatory constraints shape day-to-day operations and long-term planning.
Strengths, weaknesses, opportunities, and threats — each supported by concrete evidence from the underlying data. Moves beyond generic bullet points by tying each SWOT element to specific metrics, structural trends, or external forces identified elsewhere in the report. Useful for strategic planning and risk assessment.
Regional market concentration, wage dynamics, and emerging geographic opportunities. Breaks establishments, employment, and payroll down by state and region, identifies where the industry is densest, where it is growing fastest, and how local labor markets and wage levels differ. Standard-tier and higher includes state-level tables.
The largest public operators in the industry, named from their SEC EDGAR 10-K filings, with enterprise revenue and segment context. Sits alongside the official Census Economic Census concentration figures (CR4, CR8, CR20, CR50, HHI) so the named players can be read against the measured structure of the whole industry, public and private.
Report Preview

Low-resolution overview of all 38 pages
Want to see a full report before you buy?
Download a free sample report →Industry Analysis
The Pharmaceutical preparation manufacturing industry (NAICS 325412) encompasses 1.4K establishments in the United States employing 170.0K workers, generating an estimated ~$155.6B in annual revenue (Census Bureau). Classified within Manufacturing, the industry is positioned in a mature phase of its life cycle.
This report examines historical performance trends (2012-2025), competitive structure, geographic distribution, and provides a 5-year outlook (2026-2030) with growth drivers, risk factors, and industry-specific SWOT analysis.
Products & Services
Key service categories in the Pharmaceutical preparation manufacturing industry.
Who Uses These Reports
Trusted by professionals who need verified federal data to make decisions
Investors & PE Firms
Size markets, validate deal theses, and benchmark targets with verified federal data before committing capital
Consultants & Advisors
Deliver data-backed recommendations to clients with sourced and cited industry metrics — Census, BLS, and FRED
Founders & Operators
Validate market entry, benchmark against industry averages, and present credible data to investors and boards
Corporate Strategy Teams
Support expansion planning, M&A due diligence, and executive reporting with NAICS-classified industry data
Top Questions Answered
What is the market size of the Pharmaceutical preparation manufacturing industry?
The Pharmaceutical preparation manufacturing industry generated ~$149.9B in revenue (US Census Economic Census, 2022). Full analysis available in report.
How fast is the Pharmaceutical preparation manufacturing industry growing?
The Pharmaceutical preparation manufacturing industry has demonstrated strong growth over the measured period, outpacing the broader U.S. economy and reflecting sustained demand driven by an aging... Full analysis available in report.
What is the outlook for the Pharmaceutical preparation manufacturing industry?
The industry is projected to continue its growth trajectory, supported by powerful demographic tailwinds as the U.S. population ages and the incidence of chronic conditions such as diabetes,... Full analysis available in report.
What does NAICS 325412 — Pharmaceutical preparation manufacturing — actually cover?
NAICS 325412 covers establishments primarily engaged in manufacturing in-vivo diagnostic substances and pharmaceutical preparations — finished drugs intended for human or veterinary use — in forms... Full analysis available in report.
How many pharmaceutical preparation manufacturers operate in the United States?
As of 2023, approximately 1,400 establishments operate within the Pharmaceutical preparation manufacturing industry, employing roughly 170,000 workers (Census CBP, 2023) nationwide. Full analysis available in report.
How competitive is the Pharmaceutical preparation manufacturing industry?
Competition in pharmaceutical preparation manufacturing is shaped by exceptionally high barriers to entry, including substantial capital requirements for GMP-compliant facilities, lengthy FDA... Full analysis available in report.
How does compensation in pharmaceutical preparation manufacturing compare to other industries?
Compensation in pharmaceutical preparation manufacturing tends to be among the highest within the broader manufacturing sector, reflecting the advanced scientific, engineering, and regulatory... Full analysis available in report.
What types of companies dominate the Pharmaceutical preparation manufacturing industry?
The industry is anchored by a tier of large, globally integrated manufacturers with diversified portfolios spanning branded prescription drugs, biologics, and consumer health products, operating at a... Full analysis available in report.
Get complete answers with detailed growth rates, forecasts, and competitive analysis.
Methodology
This report is produced using AI-assisted analysis of official US government data sources. Our methodology combines automated data collection from federal statistical databases with AI-assisted synthesis and validation. Every numerical claim undergoes a validation pass against source data.
The Census Bureau's County Business Patterns and Economic Census provide establishment counts, employment, and payroll broken out by NAICS industry and geography. The Bureau of Labor Statistics QCEW program supplies wage data by industry. The Federal Reserve Economic Data (FRED) service contributes macroeconomic indicators used for industry forecasting — GDP, interest rates, housing starts, and sector-specific indices.
Data freshness varies by source: Census CBP has a ~2 year lag, BLS lags 6-9 months, and FRED provides near real-time macroeconomic data. Each report includes a data currency section showing exact year ranges.
Read our full methodology →Data Sources
Every chart, table, and claim in this report traces back to a published federal statistical database. Each data point in the PDF shows its source so you can verify it against the original dataset.
- U.S. Census Bureau — County Business Patterns & Economic Census
- Bureau of Labor Statistics — QCEW
- Federal Reserve Economic Data (FRED)
- SEC EDGAR — 10-K filings(Standard tier)
Report Details
Industry Classification (NAICS)
Where this industry sits in the North American Industry Classification System.